USE OF BETA-NICOTINAMIDE MONONUCLEOTIDE IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING ARTERIOSCLEROSIS AND CARDIO-CEREBROVASCULAR DISEASES, AND DRUGS CONTAINING THE SAME

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170165282A1
SERIAL NO

15317848

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A medication having nicotinamide mononucleotide as the active ingredient, and the use of nicotinamide mononucleotide in preparing medications for the prevention and treatment of arteriosclerosis and cardiovascular and cerebrovascular diseases caused by arteriosclerosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HOBOOMLIFE BIO-TECHNOLOGY (SHEN ZHEN) CO LTD10/F BLOCK B-3 NO 9 BUILDING SHENZHEN BAY SCIENCE AND TECHNOLOGY ECOLOGICAL PARK NANSHAN DISTRICT SHENZHEN GUANGDONG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CAI, Yanyan Shenzhen, CN 3 2
FU, Rongzhao Shenzhen, CN 24 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation